Log in to your Inderes Free account to see all free content on this page.
Scandinavian Real Heart
16.06
SEK
+7.79 %
HEART
First North Stockholm
Medical Equipment & Services
Health Care
2 following
+7.79%
-16.14%
-27.33%
-52.82%
-57.2%
-52.06%
-91.93%
-96.74%
-89.63%
realheart.se
Scandinavian Real Heart operates in medical technology. Today, the company's main focus is on research and development of heart pumps used among patients with severe heart conditions who are in the queue for transplant. The idea behind the heart pump is to use the product as a transitional solution before a final heart transplant is performed. The company is based in Västerås.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
HEART
Daily low / high price
14.54 / 16.92
SEK
Market cap
33.21M SEK
Turnover
74.94K SEK
Volume
4.6K
Financial calendar
Annual report
26.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
European Innovation Council Accelerator | 18.9 % | 18.9 % |
Eskilstunahem Förvaltnings AB | 8.1 % | 8.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Realheart Is Granted Patent Approval in India for Its Device Used in the Surgical Implantation of Realheart® TAH
Interim Report Q3 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio